Founders of India's Aurobindo Pharma to sell up to $135 million of shares - term sheet

Bs_logoImage
Reuters MUMBAI
Last Updated : Oct 06 2016 | 8:43 PM IST

MUMBAI (Reuters) - The founders of India's Aurobindo Pharma are selling shares worth up to $135 million in a block trade on Friday, according to a deal term sheet seen by Reuters.

The drugmaker is selling the shares in a price range of 810 rupees to 830 rupees, the term sheet showed.

The price range equates to a discount of between 3.1 percent and 5.5 percent of Wednesday closing price of 856.85 rupees ($12.83).

($1 = 66.7753 Indian rupees)

(Reporting by Manoj Rawal and S. Anuradha of IFR; Editing by David Goodman)

Disclaimer: No Business Standard Journalist was involved in creation of this content

You’ve hit your limit of 5 free articles this month.
Subscribe now for unlimited access.

Already subscribed? Log in

Subscribe to read the full story →
Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 06 2016 | 8:26 PM IST